BMRN - BIOMARIN PHARMACEUTICAL INC


60.43
1.900   3.144%

Share volume: 2,042,825
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.72%

PREVIOUS CLOSE
CHG
CHG%

$58.53
1.90
0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 04-26-2024 08-05-2024 10-31-2024 02-24-2025 05-02-2025 08-05-2025 10-28-2025 02-26-2026
Total revenue 648.833 M 712.029 M 745.740 M 747.313 M 745.145 M 825.410 M 776.133 M 874.565 M
Cost of revenue 125.180 M 130.459 M 188.457 M 136.139 M 151.558 M 150.090 M 140.085 M 275.709 M
Gross profit 523.653 M 581.570 M 557.283 M 611.174 M 593.587 M 675.320 M 636.048 M 598.856 M
    11.06% -4.18% 9.67% -2.88% 13.77% -5.82% -5.85%  
Operating expenses 430.893 M 446.819 M 438.381 M 440.116 M 364.847 M 393.587 M 677.893 M 638.620 M
Selling general and admin 225.906 M 263.032 M 253.480 M 266.607 M 206.116 M 232.279 M 268.415 M 446.207 M
Research and development 204.987 M 183.787 M 184.901 M 173.509 M 158.731 M 161.308 M 409.478 M 192.413 M
Total expenses 435.191 M 461.118 M 443.390 M 449.767 M 369.694 M 398.433 M 682.740 M 643.466 M
    5.96% -3.84% 1.44% -17.80% 7.77% 71.36% -5.75%  
Operating income 88.462 M 120.452 M 113.893 M 161.407 M 223.893 M 276.887 M -46.692 M -44.610 M
Ebit 89.729 M 115.925 M 119.356 M 154.536 M 221.939 M 281.720 M -41.599 M -43.585 M
Pretax income 105.547 M 132.136 M 134.441 M 169.639 M 238.089 M 297.868 M -26.324 M -27.153 M
    25.19% 1.74% 26.18% 40.35% 25.11% -108.84% 3.15%  
Income tax 16.885 M 24.962 M 28.361 M 44.696 M 52.403 M 57.336 M 4.420 M 19.420 M
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                   
Net income 88.662 M 107.174 M 106.080 M 124.943 M 185.686 M 240.532 M -30.744 M -46.573 M
    20.88% -1.02% 17.78% 48.62% 29.54% -112.78% -51.49%